DA 8031
Alternative Names: DA8031Latest Information Update: 19 Sep 2019
At a glance
- Originator Dong-A Pharmaceutical
- Developer Dong-A ST
- Class Benzofurans
- Mechanism of Action Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Premature ejaculation
Highest Development Phases
- Discontinued Premature ejaculation
Most Recent Events
- 19 Sep 2019 Discontinued - Phase-II for Premature ejaculation in South Korea (PO)
- 16 Dec 2015 Phase-II development for Premature ejaculation is ongoing in South Korea
- 01 Jan 2013 Phase-II clinical trials in Premature ejaculation in South Korea (PO)